Trial Profile
Functional and Neurochemical Brain Changes Following Successful Treatment of Early Course Bipolar Depression.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Dec 2013
Price :
$35
*
At a glance
- Drugs Lithium (Primary) ; Quetiapine (Primary)
- Indications Bipolar I disorders
- Focus Biomarker; Pharmacodynamics
- 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Feb 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov, last updated 18 Feb 2009.
- 08 Mar 2008 New trial record.